Entire group, N = 160 (%) | BS, n = 54 (%) | STS, n = 106 (%) | P-value | SRT, n = 64 (%) | MMT, n = 96 (%) | P-value | |
---|---|---|---|---|---|---|---|
Median age, years (range) | 55 (19–86) | 39 (19–80) | 59 (19–86) | < 0.001 | 66 (28–86) | 46 (19–78) | <0.001 |
Gender | 0.09 | 0.94 | |||||
Female | 74 (46) | 30 (56) | 44 (41) | 30 (47) | 44 (46) | ||
Male | 86 (54) | 24 (44) | 62 (59) | 34 (53) | 52 (54) | ||
Median time since diagnosis, years (range) | 6 (0–31) | 5 (1–22) | 6 (1–31) | 0.11 | 4 (1–19) | 6 (1–31) | 0.07 |
Time since diagnosis, years | 0.80 | 0.02 | |||||
<5 | 68 (43) | 22 (41) | 46 (43) | 34 (53) | 34 (35) | ||
≥5 | 92 (57) | 32 (59) | 60 (57) | 30 (47) | 62 (65) | ||
Treatment group | < 0.001 | ||||||
SRT | 64 (40) | 9 (17) | 55 (52) | ||||
MMT | 96 (60) | 45 (83) | 51 (48) |